These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 29315563)
1. Kinetic modeling of [ Jin H; Yue X; Liu H; Han J; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z J Neurochem; 2018 Mar; 144(6):791-804. PubMed ID: 29315563 [TBL] [Abstract][Full Text] [Related]
2. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates. Jin H; Zhang X; Yue X; Liu H; Li J; Yang H; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z Nucl Med Biol; 2016 Feb; 43(2):131-9. PubMed ID: 26872437 [TBL] [Abstract][Full Text] [Related]
4. PET Quantification of [ O'Donnell JL; Soda AK; Jiang H; Norris SA; Maiti B; Karimi M; Campbell MC; Moerlein SM; Tu Z; Perlmutter JS J Nucl Med; 2024 Jun; 65(6):956-961. PubMed ID: 38604762 [TBL] [Abstract][Full Text] [Related]
5. Radiosynthesis and evaluation of a fluorine-18 labeled radioligand targeting vesicular acetylcholine transporter. Yue X; Luo Z; Liu H; Kaneshige K; Parsons SM; Perlmutter JS; Tu Z Bioorg Med Chem Lett; 2018 Nov; 28(21):3425-3430. PubMed ID: 30274694 [TBL] [Abstract][Full Text] [Related]
6. Preclinical Evaluation and Quantification of Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720 [TBL] [Abstract][Full Text] [Related]
7. Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter. Yue X; Bognar C; Zhang X; Gaehle GG; Moerlein SM; Perlmutter JS; Tu Z Appl Radiat Isot; 2016 Jan; 107():40-46. PubMed ID: 26408913 [TBL] [Abstract][Full Text] [Related]
8. Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [ Weinstein JJ; Moeller SJ; Perlman G; Gil R; Van Snellenberg JX; Wengler K; Meng J; Slifstein M; Abi-Dargham A Biol Psychiatry; 2024 Sep; 96(5):352-364. PubMed ID: 38309322 [TBL] [Abstract][Full Text] [Related]
9. An improved synthesis of [ Hu B; Akula HK; Noh D; Mui YF; Slifstein M; Parsey R; Qu W J Labelled Comp Radiopharm; 2023 Oct; 66(12):384-392. PubMed ID: 37615234 [TBL] [Abstract][Full Text] [Related]
10. The impact of dopamine D Liu H; Luo Z; Gu J; Su Y; Flores H; Parsons SM; Zhou Y; Perlmutter JS; Tu Z Eur J Pharm Sci; 2020 Feb; 143():105152. PubMed ID: 31740395 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate. Yue X; Jin H; Liu H; Luo Z; Zhang X; Kaneshige K; Flores HP; Perlmutter JS; Parsons SM; Tu Z Org Biomol Chem; 2017 Jun; 15(24):5197-5209. PubMed ID: 28590490 [TBL] [Abstract][Full Text] [Related]
12. Decreased vesicular acetylcholine transporter related to memory deficits in epilepsy: A [ Wu XQ; Zhao YN; Ding J; Si Z; Cheng DF; Shi HC; Wang X Epilepsia; 2018 Sep; 59(9):1655-1666. PubMed ID: 30126014 [TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Petrou M; Frey KA; Kilbourn MR; Scott PJ; Raffel DM; Bohnen NI; Müller ML; Albin RL; Koeppe RA J Nucl Med; 2014 Mar; 55(3):396-404. PubMed ID: 24481024 [TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme. Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356 [TBL] [Abstract][Full Text] [Related]
15. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine. Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057 [TBL] [Abstract][Full Text] [Related]
16. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology. Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290 [TBL] [Abstract][Full Text] [Related]
17. Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the Brain. Luo Z; Liu H; Jin H; Gu J; Yu Y; Kaneshige K; Perlmutter JS; Parsons SM; Tu Z ChemMedChem; 2018 Sep; 13(18):1978-1987. PubMed ID: 30071131 [TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of [ Liang Q; Joshi S; Liu H; Yu Y; Zhao H; Benzinger TLS; Perlmutter JS; Tu Z Eur J Pharmacol; 2021 Nov; 911():174556. PubMed ID: 34627806 [TBL] [Abstract][Full Text] [Related]
19. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain. Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566 [TBL] [Abstract][Full Text] [Related]
20. Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging. Barret O; Mazère J; Seibyl J; Allard M J Cereb Blood Flow Metab; 2008 Sep; 28(9):1624-34. PubMed ID: 18506194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]